Mark your calendars for the 2019 Sickle Cell Disease Therapeutics Conference on Sept. 10th in Washington, DC. SCDAA’s Chief Medical Officer, Dr. Biree Andemariam, and President/CEO Beverley Francis-Gibson, will serve as a panelist and host, respectively. The Annual Sickle Cell Disease Therapeutics Conference is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Conference attendees will hear presentations from healthcare companies, key opinion leaders, patients, policy makers and others.
Register today to attend the forum that will discuss the latest advancements and future trends for treating patients with sickle cell disease.
Click here to register!
